Sensei Biotherapeutics Rings the Nasdaq Stock Market Closing Bell
Sensei Biotherapeutics (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, John Celebi, President & Chief Executive Officer of Sensei Biotherapeutics, rings the Closing Bell.